---
title: "Confido Health Adds $12.5M to Bring Series A to $22.5M"
description: "Confido Health added a $12.5 million Series A extension led by Z47, bringing the round total to $22.5 million for its CareOS healthcare operations platform."
date: 2026-10-14T00:00:00.000Z
source: https://venturecapitaltracker.com/confido-health-12-5m-series-a-extension-careos
---

# Confido Health Adds $12.5M to Bring Series A to $22.5M

> Confido Health added a $12.5 million Series A extension led by Z47, bringing the round total to $22.5 million for its CareOS healthcare operations platform.

Confido Health has added a **$12.5 million extension** to its Series A, bringing the round to **$22.5 million**. Z47, formerly Matrix Partners India, led the new financing. Healthcare investor Justin Saks joined as an investor and board adviser, while Together Fund and Blume Ventures returned.

The company is using the capital to expand CareOS, a platform of coordinated AI agents for healthcare operations. Confido previously focused on voice agents; it now describes its product as a broader “system of action” that works above existing systems of record.

## Financing details

| Item | Detail |
|---|---|
| New capital | $12.5 million |
| Series A total | $22.5 million |
| Lead | Z47 |
| Other investors | Justin Saks, Together Fund and Blume Ventures |
| Valuation | Undisclosed |

The distinction between the extension and the round total matters. Confido did not raise a fresh $22.5 million in October; the new money is $12.5 million.

## From voice agent to operating layer

CareOS is intended to automate tasks such as patient calls, appointment scheduling, insurance verification, prescription refills and payment follow-up. The product thesis is that healthcare organizations already possess the necessary data, but their systems do not consistently act on it.

That is an attractive problem because administrative labor is expensive and fragmented across clinics, call centers and revenue-cycle teams. It is also difficult. Healthcare workflows contain exceptions, sensitive data and consequences that make silent errors unacceptable.

Confido's move from a narrow voice product to a multi-agent operating layer can increase contract value and make the platform harder to replace. It also increases integration and reliability requirements. Each additional workflow creates more dependencies on electronic health records, practice-management systems, payers and human escalation rules.

## Competitive position

Confido competes with healthcare conversational-AI vendors such as Hyro and Infinitus, broader clinical-agent companies, and incumbent practice software adding automation. Its opportunity is to coordinate tasks across systems rather than sell a single bot.

Private-equity-backed medical groups are an important customer segment because they operate multiple sites and have a clear incentive to standardize labor-intensive workflows. The risk is that integration work becomes bespoke and limits software margins.

The Series A extension gives Confido more capital to expand beyond scheduling. Investors will need evidence that deployments remain auditable, that agents improve collections or access without harming patient experience, and that CareOS can be implemented repeatedly rather than rebuilt for every healthcare group.

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.